Press Releases

Glox Therapeutics Awarded £1M PACE Grant to Accelerate Development of Precision Antibiotics Against Antimicrobial-resistant Pathogens

PathAI Announces Integrations with Leading AI-pathology companies Deep Bio, DoMore Diagnostics, Paige, and Visiopharm, through its AISight Image Management System

PathAI, a global leader in AI-powered digital pathology solutions and the developer of the market-leading AISight1 Image Management System (IMS), today announced the integration of several AI products from market leading digital pathology companies, including Deep Bio, DoMore Diagnostics, Paige, and Visiopharm. Through these collaborations, PathAI will provide algorithms from these developers directly within its AISight IMS, reinforcing its commitment to offering the most versatile, reliable, and interoperable IMS on the market.

Illumina Rolls out MiSeq i100 Series to Reshape Next-Generation Sequencing

The MiSeq i100 Series of sequencing equipment was introduced by Illumina, a multinational corporation dedicated to DNA sequencing and array-based technologies. The new systems are designed to improve next-generation sequencing (NGS) capabilities for labs by providing quick turnaround and user-friendliness.

Owkin And Proscia Expand Access To AI Pre-Screening For Colorectal Cancer Patients

Owkin’s MSIntuit® CRC v2, a next-generation AI diagnostic aimed at transforming the detection and treatment of colorectal cancer, will be integrated into Proscia’s Concentriq® software platform, making it available as part of Proscia’s precision medicine AI portfolio.

Sakura Finetek Europe and MEDIPATH announced their collaboration to improve patient journey for cancer screenings and diagnoses

Sakura Finetek Europe and MEDIPATH announced their collaboration to enhance cancer diagnostics and thus contribute to improved patient therapeutic management.

City Therapeutics Debuts with $135M Series A to Revolutionize RNAi-Based Therapeutics

City Therapeutics, which uses next-generation engineering of small interfering RNAs (siRNAs) to drive improvements in RNA interference (RNAi)--based therapeutics, has announced its debut along with a $135 million Series A funding.

Coronado Research Limited announce the appointment of Alexander McCormick as Chief Commercial Officer

Coronado Research announced today that Alexander McCormick has been appointed as Chief Commercial Officer.

Augurex and New Day Diagnostics Announce Launch of Anti-14-3-3eta Multiplex Analyte Specific Reagents; Enabling a First-In-Class Diagnostic Test for Axial Spondyloarthritis

• Augurex launches Anti-14-3-3eta Multiplex Analyte Specific Reagents (ASRs), supporting the development of a first-in-class diagnostic test for axial spondyloarthritis (axSpA) by New Day Diagnostics. • The new laboratory developed test, which uses Anti-14-3-3eta Multiplex ASRs as components, aims to reduce the extensive diagnostic delay typically experienced by axSpA patients, provide clinicians with a reliable tool to help improve patient outcomes, and potentially aid the early diagnosis and treatment of axSpA.

Association for Molecular Pathology Publishes Joint Consensus Report on SARS-CoV-2 Genomic Surveillance for Clinical Hospitals and Public Health Laboratories

AMP announced a joint consensus report with APHL that describes best practices and offers key pre-analytical, analytical, and post-analytical considerations to help improve critical NGS-based surveillance programs.

Gifthealth Announces Strategic Partnership with United Digestive

Partnership expands Gifthealth’s presence to cover 25% of gastroenterologists nationally.

Oxford Nanopore and Wasatch BioLabs Announce Collaboration to Transform DNA Methylation Analysis with New dWMS Product

The collaborative development between Oxford Nanopore and Wasatch BioLabs marks an exciting milestone in the field of epigenetics and signals a commitment to empowering researchers with innovative, reliable tools. As the product nears its anticipated market release, the scientific community awaits a new era of discovery and understanding in methylation research, fueled by real-time, comprehensive insights into the methylome.

William H Morris, MD MBA, Joins Ambience Healthcare as Chief Medical Officer

MMS Named a Finalist in the 2024 Fierce CRO Awards for Leadership in Regulatory Compliance

MMS has announced that its regulatory team has been selected as one of three top finalists in the Fierce CRO Awards for Leadership in Regulatory Compliance.

Octalsoft Honored with Times Gujarat Icon 2024 Award for Excellence in Technology and Innovation

Octalsoft, a global leader in clinical trial and healthcare technology solutions, is proud to announce its recognition as a Times Gujarat Icon 2024 Award winner, acknowledging the company’s exceptional contributions to the technology and healthcare sectors.

PathAI Launches PathExplore™ Fibrosis: An AI-Powered Pathology Breakthrough in Fibrosis, Collagen, and Fiber Quantification Directly from Whole Slide Images

PathAI’s solution facilitates this analysis directly from routine H&E pathology images from standard imaging platforms, democratizing access to key insights into tumor biology and therapeutic responses without the need of custom microscopy.

Sunbird Bio Presents New Clinical Data Demonstrating Proprietary Alpha Synuclein Blood-Based Biomarkers Could Accurately Diagnose Parkinson’s Disease

Sunbird’s diagnostic technology classified Parkinson’s disease-positive blood samples with 86% accuracy through the direct detection of aggregated alpha synuclein proteins.

VIZIA Diagnostics Selects PathAI and the AISight Image Management System to Support the Transition to Digital and AI-Powered Pathology

PathAI, a leader in digital and AI-powered pathology solutions, and VIZIA Diagnostics, a GI- specialized pathology laboratory based in Alpharetta, Georgia, have announced that VIZIA has adopted PathAI’s AISightⓇ1 Image Management System (IMS) and AI technology to advance the precision and operational efficiency of its pathology services.

Takara Bio Europe Expands Existing Gothenburg Site to Offer Custom Enzyme Manufacturing

Takara Bio Europe has announced the expansion of its Gothenburg facility, with the addition of a custom manufacturing lab. This new facility now offers a comprehensive array of customised molecular biology products, including PCR and qPCR enzymes, servicing the molecular biology needs of academic researchers, diagnostic labs, and biotech companies across EMEA, producing up to 600,000 reactions per week. With these expanded capabilities, customers can expect faster deliveries, personalised service, and real-time access to technical expertise, ensuring projects move forward efficiently while supporting sustainability goals through reduced carbon emissions.

CluePoints Appoints Richard Young as Chief Strategy Officer

RBQM innovator CluePoints has today announced that Richard Young has been appointed as its new Chief Strategy Officer. With 30 years of experience in clinical data management, Richard is an expert in his field.

Coronado Research Limited announce appointment of Professor Jennifer Visser-Rogers as Chief Scientific Officer

Coronado Research announced today that Professor Jennifer Visser-Rogers has been appointed as Chief Scientific Officer.